- Home
- SSRM vs CDNA Comparison
SSRM vs CDNA Comparison
Compare SSRM & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSRM
- CDNA
- Stock Information
- Founded
- SSRM 1946
- CDNA 1998
- Country
- SSRM United States
- CDNA United States
- Employees
- SSRM N/A
- CDNA N/A
- Industry
- SSRM Precious Metals
- CDNA Medical Specialities
- Sector
- SSRM Industrials
- CDNA Health Care
- Exchange
- SSRM Nasdaq
- CDNA Nasdaq
- Market Cap
- SSRM 1.5B
- CDNA 1.1B
- IPO Year
- SSRM 1996
- CDNA 2014
- Fundamental
- Price
- SSRM $7.18
- CDNA $21.52
- Analyst Decision
- SSRM Hold
- CDNA Buy
- Analyst Count
- SSRM 3
- CDNA 8
- Target Price
- SSRM $5.18
- CDNA $27.17
- AVG Volume (30 Days)
- SSRM 3.0M
- CDNA 691.6K
- Earning Date
- SSRM 02-19-2025
- CDNA 02-26-2025
- Dividend Yield
- SSRM N/A
- CDNA N/A
- EPS Growth
- SSRM N/A
- CDNA N/A
- EPS
- SSRM N/A
- CDNA N/A
- Revenue
- SSRM $1,098,328,000.00
- CDNA $312,775,000.00
- Revenue This Year
- SSRM N/A
- CDNA $19.85
- Revenue Next Year
- SSRM $16.66
- CDNA $11.34
- P/E Ratio
- SSRM N/A
- CDNA N/A
- Revenue Growth
- SSRM N/A
- CDNA 5.26
- 52 Week Low
- SSRM $3.76
- CDNA $7.42
- 52 Week High
- SSRM $10.81
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- SSRM 58.41
- CDNA 41.67
- Support Level
- SSRM $6.79
- CDNA $20.35
- Resistance Level
- SSRM $7.18
- CDNA $21.68
- Average True Range (ATR)
- SSRM 0.27
- CDNA 1.13
- MACD
- SSRM -0.05
- CDNA -0.04
- Stochastic Oscillator
- SSRM 30.71
- CDNA 30.62
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.